MedPath

Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow

Not Applicable
Completed
Conditions
Lateral Epicondylosis
Tennis Elbow
Lateral Epicondylitis
Interventions
Procedure: Radial extracorporeal shock wave therapy (rESWT)
Procedure: sham shockwave therapy
Procedure: Physical therapy
Registration Number
NCT02596659
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

Background:

Tennis elbow, also known as lateral epicondylitis, is the inflammatory status of insertion site of common extensor tendon to humerus. It is usually related to overuse of local muscle. Radial extracorporeal shock wave therapy (rESWT) is a non-invasive physical treatment. It applies shockwave energy to the lesion site, enhancing the growth of microvascularity, inducing tissue repair, and thus relieving the symptom.

The purpose of this study is to understand the therapeutic effect of rESWT to tennis elbow.

Material and Methods

* Subjects: 30 patients will be recruited from outpatient department of physical medicine and rehabilitation department.

* Duration: 2013.09.01-2015.05.31

* Methods: The patients will be randomly divided into the experimental group and the control group through the draw, with 15 patients in each group. Patients in the experimental group receive rESWT plus routine rehabilitation program. Patients in the control group receive sham shockwave therapy plus routine rehabilitation program.

* Assessment: Before the therapy starts, patients who match the inclusion criteria will be evaluated using tools mentioned below:

* General data: age, sex, body height, body weight, affected side, medical history

* Assess upper extremity function and symptom with Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)

* Assess severity of pain with Visual Analogue Scale (VAS)

* Assess grip strength with grip strength dynamometer

* Measure the size of tear (if any) of common extensor tendon through ultrasonography, and assess the texture of common extensor tendon through real-time sonoelastography (RTS)

Patients will be followed up 6 weeks, 3months, and 6 months after therapy starts. They will be re-assessed of upper extremity function and symptom, severity of pain, grip strength, and presentation on ultrasonography and RTS.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Aged > 18 years old
  • Lateral elbow pain lasting > 3 months
  • Pain induced by direct compression on the lateral epicondyle or common extensor tendon, resistant wrist extension and pronation in the elbow extension position, or static stretching of common extensor tendon through the palmer flexion in wrist pronation and elbow extension position
Exclusion Criteria
  • Generalized inflammatory arthritis (e.g., rheumatic arthritis)
  • Pain at the proximal part of involved arm (e.g., shoulder pain, neck pain)
  • Pain other than elbow pain at the involved arm
  • Abnormal neurogenic symptom over the involved arm (e.g., radicular pain, hands numbness, hemiplegia)
  • Wound or skin lesion at the elbow of the involved arm
  • Pregnancy
  • Severe local or systemic infection
  • Malignancy
  • Coagulopathy
  • Cardiac pacemaker
  • History of surgical treatment at the elbow of the involved arm
  • Non-steroid anti-inflammatory drug (NSAID) use orally or topically at the elbow of the involved arm in the past week
  • Local steroid injection at the elbow of the involved arm in the past 3 months
  • Oral steroid use in the past 6 weeks
  • Refusal to sign the informed consent
  • Impairment in self-expression (e.g., dementia, aphasia)
  • Inability/unwillingness to participate in all the measurements.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
The experimental groupPhysical therapyParticipants in the experimental group received radial extracorporeal shock wave therapy (rESWT) plus physical therapy for 3 weeks.
The experimental groupRadial extracorporeal shock wave therapy (rESWT)Participants in the experimental group received radial extracorporeal shock wave therapy (rESWT) plus physical therapy for 3 weeks.
The control groupsham shockwave therapyParticipants in the control group received sham shockwave therapy plus physical therapy for 3 weeks.
The control groupPhysical therapyParticipants in the control group received sham shockwave therapy plus physical therapy for 3 weeks.
Primary Outcome Measures
NameTimeMethod
Changes in upper limb functionAt baseline, 6 weeks, 12 weeks and 24 weeks

Upper extremity disability and symptoms were assessed using the Taiwan version Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire.

Changes in stiffness of common extensor tendonAt baseline, 6 weeks, 12 weeks and 24 weeks

The changes in stiffness of common extensor tendon were assessed with sonoelastography. The images of sonoelastography were interpreted with the modified RTS scoring system and analyzed with color histogram.

Changes in grip strengthAt baseline, 6 weeks, 12 weeks and 24 weeks

Maximal grip strength of the involved arm was assessed using a grip strength dynamometer. Participants were asked to grip the dynamometer 3 times, at 15- second rest intervals, and the highest grip strength number was recorded.

Changes in pain intensityAt baseline, 6 weeks, 12 weeks and 24 weeks

Participants were asked to rate their present pain intensity, as caused by the tennis elbow, from 0-10 using the Visual Analogue Scale (VAS). If participants had bilateral tennis elbow, the side with the worse pain intensity was chosen for the assessment.

Secondary Outcome Measures
NameTimeMethod
Changes in size of tear within common extensor tendonAt baseline, 6 weeks, 12 weeks and 24 weeks

On the 2-D image, the common extensor tendon was located. If there was tear within common extensor tendon, diameters in the 3-D dimension were measured and the size of the tear was calculated as a spheroid.

Trial Locations

Locations (1)

Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung city, Taiwan

© Copyright 2025. All Rights Reserved by MedPath